Agilent | Trusted AnswersAgilent | Trusted Answers

Preparative Liquid Chromatography
User Group Meeting

May 6, 2025 | Lexington, MA

Prep LC User Group Meeting | Agilent

Join us for the our Preparative HPLC User Group Meeting!

Location

Agilent Center of Excellence - Lexington

121 Hartwell Ave.,
Lexington, MA 02421

This premier event is dedicated to the exploration and discussion of cutting-edge chromatographic purification techniques and is the perfect platform to explore the latest advancements, share insights, and connect with peers in the field. Network, join a round table discussion, and hear from industry experts on topics likeearly drug discovery, and productivity in high-throughput labs. This event is free to attend but seating is limited so reserve your spot today!

Register now

Agenda & Abstracts

 

9:30 a.m. – 10:00 a.m. Check-in
10:00 a.m. – 10:15 a.m. Welcome & Agenda Review
10:15 a.m. – 11:00 a.m. Lab Tour
11:00 a.m. – 11:45 a.m. Streamlining Mass Directed Preparative HPLC in Early Drug Discovery
11:45 a.m. – 12:30 p.m. Principles of Method Development in Preparative Liquid Chromatography: Demystifying Purification Workflows
12:30 p.m. – 1:30 p.m. Lunch
1:30 p.m. – 2:15 p.m. Enhancing Efficiency and Productivity within a High Throughput Separations Lab

2:15 p.m. – 3:00 p.m.

Mass-guided auto-purification of synthetic peptides on preparative and semi-preparative scales 
3:00 p.m. – 3:15 p.m.   Coffee Break
3:15 p.m. – 4:00 p.m.  Round Table Discussion
4:00 p.m. – 5:00 p.m. Mixer
Register now

Streamlining Mass Directed Preparative HPLC in Early Drug Discovery

Purification of target compounds from crude synthetic mixtures has always been a rate limiting step in the new molecular entity discovery process. Typical technologies employed either have limited resolving power, but simple guiding principles (Flash Chromatography, TLC) or high resolving power but no simple universal rules (Mass-directed HPLC). Incorporating Agilent’s state-of-the-art Analytical-to Prep software in our purification process resulted in dramatic increase in throughput and significant decrease in turnaround time. Our overall process draws on the years of experience of our staff and has been utilized to purify thousands of compounds. This presentation describes the steps from prepurification to FinalQC and the best practices to obtain the preparative conditions to isolate the target molecules from a wide variety of synthetic mixtures. Several case studies will be presented.

Mass-guided auto-purification of synthetic peptides on preparative and semi-preparative scales

Fully automated solid-phase peptide synthesis (SPPS) can produce hundreds, if not thousands, of peptides to propel medicinal chemistry programs in early drug discovery against targets of interest.  Due to substantial bottlenecks associated with manual purification, when using these high-throughput synthesis techniques, molecules are tested as crude mixtures ranging from 20-70% purities depending on peptide length and synthesis efficiency.  This can lead to confounded rank-ordering of active molecules, as well as preventing analysis of other key aspects of ‘drug-likeness’ such as solubility, biophysical characteristics, stability, etc.  Mass-guided, automated purification provides a dramatic benefit to exploration of structure-activity relationships and drug-like properties by expanding the purification bottleneck.  This presentation will describe the instrumentation, methods, and workflows associated with a typical peptide medicinal chemistry program, and how mass-guided auto-purification expands the screening funnel to provide more high-quality data for lead molecule discovery.

Enhancing Efficiency and Productivity within a High Throughput Separations Lab

This talk will focus on enhancing efficiency and productivity within a high throughput separations lab. The presentation will explore equipment suggestions, lab optimization strategies, and 'best practices' to enhance the day-to-day operation of Agilent Preparative LCMS systems. Additionally, an alternative 'run engine' will be discussed for controlling Agilent ChemStation software, which facilitates the seamless interpretation of analytical datafiles and the generation of optimized preparative gradients.

Principles of Method Development in Preparative Liquid Chromatography: Demystifying Purification Workflows

Compound purification by liquid chromatography is part of an industrial process with the aim of obtaining ideally highly pure compounds after their separation from a crude mixture. But there is also a need of including aspects which will lead to more efficiency and cost reduction. The selection of the right column dimensions for your task, strategies for upscaling, the selection of the most affordable solvents, sample throughput and automation are often the variables which must be set with due diligence in advance. In this lesson we will learn how to differentiate between three selected common purification workflows, therefore I will guide you through the basics of method development from each of them.

Speakers

Laszlo Varady, PhD, Rilas Technologies

Founder and CEO of Rilas Technologies, Inc.

He founded Rilas Technologies in 2009 to offer groundbreaking services to medicinal chemistry labs that are tasked with meeting both operational and scientific challenges. Prior to founding Rilas, Laszlo worked as a Vice President at Anthill Technologies, where he managed the company’s high throughput purification and analysis. Laszlo spent almost nine years at ArQule where he managed the Application Development group and developed solid phase synthetic methods on Agarose leading to a set of ligands for protein affinity chromatography. Prior to ArQule Laszlo was Director of Surface Chemistry at PerSeptive Biosystems where he developed a wide range chromatographic stationary phases based on a coated polystyrene for biomolecule separations. Laszlo got his M.S. in Chemical Engineering and a Ph. D. in Biochemistry from Budapest University of Technology and Economics. He also completed post-doctoral work with Professor Csaba Horvath, Ph.D., of Yale University, and Professor Fred Regnier, Ph.D., of Purdue University. Laszlo holds numerous patents and has published a number of papers.

David Smith, Merck Technologies

David Smith is a Separations Scientist at Merck & Co., Inc., based in Boston, MA. With over two decades of experience operating preparative HPLC-MS systems in high-throughput environments, David has made significant contributions to the development and optimization of reverse-phase purification workflows across the Merck network. He holds a B.S. in Chemistry from Worcester State University and has further enhanced his expertise through various certifications from leading industry institutions.

David Hymel, Novo Nordisk

I received a B.S. in Chemistry from Louisiana State University in 2008, followed by a Ph.D. in Medicinal Chemistry from the University of Kansas in 2014.  I followed my Ph.D. with a postdoctoral fellowship at the Chemical Biology Laboratory of the National Cancer Institute focusing on the development of peptidomimetics as inhibitors of oncology-relevant targets.  I began my industry career in 2017 at Novo Nordisk Research Center in Seattle and transferred to the newly formed Novo Nordisk Research & Development site in Lexington, MA in 2023.

Register now

Your Personal Data

* This field is required

Please select your application interest(s) from choices below.

Please select your technique(s) from choices below.

Your Purchase Plan











For full details of how we will treat your information please view our privacy policy: www.agilent.com/home/privacy-policy